QT

DGAP-News: Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)

Thursday, October 14, 2021 - 2:29pm

Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • Having a global drug development strategy ensures economy of scale and lower cost of drug development to shareholders.
  • The REBORN(c) clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF(TM) to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF(TM) to a late clinical development stage.

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™

Thursday, October 14, 2021 - 11:30am

Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • The Company completed two Phase 1 clinical trials in healthy volunteers to assess the safety profile, including cardiovascular, pharmacodynamics and pharmacokinetics, of smoked and vaporized QIXLEEF.
  • The REBORN clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF to a late clinical development stage.

Tolmar Establishes Tolmar Canada to Sell, Market and Distribute ELIGARD® in Canada

Friday, October 8, 2021 - 3:30pm

BUFFALO GROVE, Ill., Oct. 8, 2021 /PRNewswire/ -- Tolmar, a specialty pharmaceutical company, today announced that, effective January 1, 2022, the company will hold exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in Canada. ELIGARD® is a prescription medication for the palliative treatment of advanced prostate cancer.

Key Points: 
  • With the establishment of Tolmar Pharmaceuticals Canada, Tolmar will resume the rights to ELIGARD in the Canadian market.
  • Tolmar will exclusively market, sell, and distribute ELIGARD in Canada after those respective dates.
  • "We are excited to regain the sales and marketing rights for ELIGARDin Canada," said Anil D'souza, CEO of Tolmar Pharmaceuticals.
  • The establishment of Tolmar Pharmaceuticals Canada will allow Tolmar to continue to advance ELIGARDinto the future."

Fomo Baby: A New DeFi Token With A Revolutionary Concept of Price-Elastic Tokens

Monday, October 4, 2021 - 11:31am

LOS ANGELES, Oct. 4, 2021 /PRNewswire/ --Fomo Baby is a new DeFi token with an innovative structure.

Key Points: 
  • LOS ANGELES, Oct. 4, 2021 /PRNewswire/ --Fomo Baby is a new DeFi token with an innovative structure.
  • In their revolutionary approach to handle degrading charts, Fomo Baby introduces the idea of Rebase or Price-Elastic tokens.
  • As an example,
    Say an investor is holding 200 tokens of Fomo Baby at $1 per token price, amounting to a total value of $200.
  • Once the price rebases feature is implemented, the investor will have 100 tokens at $2 per token price.

Fomo Baby: A New DeFi Token With A Revolutionary Concept of Price-Elastic Tokens

Monday, October 4, 2021 - 11:29am

LOS ANGELES, Oct. 4, 2021 /PRNewswire/ --Fomo Baby is a new DeFi token with an innovative structure.

Key Points: 
  • LOS ANGELES, Oct. 4, 2021 /PRNewswire/ --Fomo Baby is a new DeFi token with an innovative structure.
  • In their revolutionary approach to handle degrading charts, Fomo Baby introduces the idea of Rebase or Price-Elastic tokens.
  • As an example,
    Say an investor is holding 200 tokens of Fomo Baby at $1 per token price, amounting to a total value of $200.
  • Once the price rebases feature is implemented, the investor will have 100 tokens at $2 per token price.

All-Clad Metalcrafters Pledges $50,000 To Breast Cancer Research Foundation Ahead of Breast Cancer Awareness Month

Wednesday, September 29, 2021 - 2:24pm

PARISIPPANY, N.J., Sept. 29,2021 /PRNewswire/ -- In support of Breast Cancer Awareness Month, All-Clad Metalcrafters, the premium cookware brand for both professional chefs and passionate home cooks alike, pledge a $50,000 minimum donation to the Breast Cancer Research Foundation (BCRF).

Key Points: 
  • PARISIPPANY, N.J., Sept. 29,2021 /PRNewswire/ -- In support of Breast Cancer Awareness Month, All-Clad Metalcrafters, the premium cookware brand for both professional chefs and passionate home cooks alike, pledge a $50,000 minimum donation to the Breast Cancer Research Foundation (BCRF).
  • For the month of October, All-Clad will feature several BCRF initiatives across All-Clad.com , including limited-edition products to fund the organization's research, curated recipes from BCRF nutritionists, breast cancer prevention tips and more.
  • To learn more and make a donation to the Breast Cancer Research Foundation, visit all-clad.com/bcrf , and follow @allclad on Instagram to stay up to date on the latest news.
  • Founded in 1993 by Evelyn H. Lauder, the Breast Cancer Research Foundation is the largest private funder of breast cancer research in the world.

Monitor Patient Adverse Drug Effects with New-Age Digital Health Tools, Upcoming Webinar Hosted by Xtalks

Friday, September 24, 2021 - 1:30pm

Because certain medications may have potential adverse effects on patients, many healthcare professionals reconsider prescribing them, despite some of these medications having a higher efficacy than their alternatives.

Key Points: 
  • Because certain medications may have potential adverse effects on patients, many healthcare professionals reconsider prescribing them, despite some of these medications having a higher efficacy than their alternatives.
  • In this webinar, speakers from AliveCor and Market Dynamics will discuss how digital health tools are currently being used to enhance personalized medicine through cardiac safety monitoring programs.
  • Register for this webinar to learn how the adoption of digital health tools can improve patient outcomes by providing accurate, personalized, medical-grade data when it matters most.
  • For more information, or to register for this event, visit Monitor Patient Adverse Drug Effects with New-Age Digital Health Tools.

New Circulon SteelShield™ Technology Cookware

Wednesday, September 22, 2021 - 1:25pm

VALLEJO, Calif., Sept. 22, 2021 /PRNewswire/ -- Meyer Corporation, U.S., a leading cookware company that invented gourmet quality nonstick cookware with the introduction of Circulon in 1985, reinvents the category again and announces its new state of the art Circulon SteelShield Technology Cookware in two collections, the tri-ply clad C Series andbrushed stainless steel S Series.

Key Points: 
  • VALLEJO, Calif., Sept. 22, 2021 /PRNewswire/ -- Meyer Corporation, U.S., a leading cookware company that invented gourmet quality nonstick cookware with the introduction of Circulon in 1985, reinvents the category again and announces its new state of the art Circulon SteelShield Technology Cookware in two collections, the tri-ply clad C Series andbrushed stainless steel S Series.
  • Available now at www.Circulon.com and retail stores nationwide, Circulon SteelShield Technology combines the best of both worlds the strength and beauty of steel cookware with nonstick that really lasts.
  • Circulon SteelShield Technology allows home cooks to fearlessly tackle everyday cooking with high-performance cookware that delivers stainless steel performance with much easier cleanup, and is built for life.
  • For further information on Circulon SteelShield Technology Cookware and other Circulon kitchen products, consumers are welcomed to visit Circulon.com .

Leucadia Asset Management Announces Strategic Relationship with Manteio Capital

Wednesday, September 22, 2021 - 1:00pm

Leucadia Asset Management, a division of Jefferies Financial Group Inc. (NYSE: JEF), today announced a strategic relationship with Manteio Capital (Manteio), a systematic investment manager employing quantitative strategies and Artificial Intelligence (AI) methodologies.

Key Points: 
  • Leucadia Asset Management, a division of Jefferies Financial Group Inc. (NYSE: JEF), today announced a strategic relationship with Manteio Capital (Manteio), a systematic investment manager employing quantitative strategies and Artificial Intelligence (AI) methodologies.
  • In connection with the transaction, Leucadia Asset Management will invest long-term capital into Manteios offering of systematic strategies.
  • We are thrilled to be entering into this strategic relationship with Leucadia Asset Management and look forward to successfully developing and growing the business together over the long-term.
  • Leucadia Asset Management offers institutional clients an innovative range of investment strategies through its affiliated asset managers.

EPEIOS 14-Liter 6-in-1 Air Fryer Oven Makes Cooking A Cinch

Wednesday, September 15, 2021 - 3:24am

As a growing number of people have prioritized cooking at home, EPEIOS makes it even easier to avoid unhealthy choices without losing flavor by the EPEIOS CP247A the latest model in the Epicure+ Air Fryer Oven series, a highly-functional air fryer with much larger capacity like an oven.

Key Points: 
  • As a growing number of people have prioritized cooking at home, EPEIOS makes it even easier to avoid unhealthy choices without losing flavor by the EPEIOS CP247A the latest model in the Epicure+ Air Fryer Oven series, a highly-functional air fryer with much larger capacity like an oven.
  • EPEIOS CP247A air fryer oven covers 6 functions: air fry, oven, bread toaster, food dryer, defrost, and dough proofing.
  • Epeios CP247Aair fryer oven use a 360-degree circulation of hot air to cook food and the temperature can go up to 220 C (428 F).
  • While most air fryers in the market come with limited capacity that might only be suitable for up to 2 people's meals, EPEIOS air fryer oven, as a specific type of air fryer, innovatively offers a larger capacity with less counter space take up.